Literature DB >> 23205280

Six minute walking test and carbon monoxide diffusing capacity for non-small cell lung cancer: easy performed tests in every day practice.

Paul Zarogoulidis1, Theodora Kerenidi, Haidong Huang, Theodoros Kontakiotis, Ourania Tremma, Konstantinos Porpodis, Anastasios Kalianos, Ageliki Rapti, Christoforos Foroulis, Athanasios Zissimopoulos, Nikolaos Courcoutsakis, Konstantinos Zarogoulidis.   

Abstract

BACKGROUND: Several studies have demonstrated that reduced lung function is a significant risk factor for lung cancer and increased surgical risk in patients with operable stages of lung cancer. The aim of the study was to perform pulmonary function tests and investigate which is a favorable respiratory function test for overall survival between lung cancer stages.
METHODS: Lung function tests were performed to lung cancer patients with non-small cell lung cancer of stage I, II, III and IV (241 patients in total). They had the last follow-up consecutively between December 2006 and July 2008. The staging was decided according to the sixth edition of TNM classification of NSCLC. The Forced Expiratory Volume in 1sec (FEV1), Forced Vital Capacity (FVC) and Carbon Monoxide Diffusing Capacity (DLCO) were measured according to American Thoracic Society/European Respiratory Society guidelines. The 6 Minute Walking Test (6MWT) was measured according to the American Thoracic Society.
RESULTS: There was a significant association of the DLCO upon diagnosis and overall survival for stage II (P<0.007) and IV (P<0.003). Furthermore, there was a significant association between 6MWT and overall survival for stage III (P<0.001) and stage IV (P<0.010).
CONCLUSIONS: The significance for each lung function test is different among the stages of NSCLC. DLCO and 6MWT upon admission are the most valuable prognostic factors for overall survival of NSCLC.

Entities:  

Keywords:  6MWT; DLCO; FEV1; FVC; NSCLC

Year:  2012        PMID: 23205280      PMCID: PMC3506801          DOI: 10.3978/j.issn.2072-1439.2012.08.18

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  45 in total

1.  ATS statement: guidelines for the six-minute walk test.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2002-07-01       Impact factor: 21.405

2.  Prognostic factors for survival in stage III non-small-cell lung cancer treated with definitive radiation therapy: impact of tumor volume.

Authors:  Kiyoshi Basaki; Yoshinao Abe; Masahiko Aoki; Hidehiro Kondo; Yoshiomi Hatayama; Shigeyuki Nakaji
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-10-13       Impact factor: 7.038

3.  ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy).

Authors:  A Brunelli; A Charloux; C T Bolliger; G Rocco; J-P Sculier; G Varela; M Licker; M K Ferguson; C Faivre-Finn; R M Huber; E M Clini; T Win; D De Ruysscher; L Goldman
Journal:  Eur Respir J       Date:  2009-07       Impact factor: 16.671

4.  Diffusion lung capacity for carbon monoxide (DLCO) is an independent prognostic factor for long-term survival after curative lung resection for cancer.

Authors:  Michael J Liptay; Sanjib Basu; Michael C Hoaglin; Neil Freedman; L Penfield Faber; William H Warren; Zane T Hammoud; Anthony W Kim
Journal:  J Surg Oncol       Date:  2009-12-15       Impact factor: 3.454

Review 5.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary.

Authors:  R A Pauwels; A S Buist; P M Calverley; C R Jenkins; S S Hurd
Journal:  Am J Respir Crit Care Med       Date:  2001-04       Impact factor: 21.405

6.  Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study.

Authors:  D J Hole; G C Watt; G Davey-Smith; C L Hart; C R Gillis; V M Hawthorne
Journal:  BMJ       Date:  1996-09-21

7.  The lung cancer exercise training study: a randomized trial of aerobic training, resistance training, or both in postsurgical lung cancer patients: rationale and design.

Authors:  Lee W Jones; Neil D Eves; William E Kraus; Anil Potti; Jeffrey Crawford; James A Blumenthal; Bercedis L Peterson; Pamela S Douglas
Journal:  BMC Cancer       Date:  2010-04-21       Impact factor: 4.430

8.  The 6-min walk distance: change over time and value as a predictor of survival in severe COPD.

Authors:  V M Pinto-Plata; C Cote; H Cabral; J Taylor; B R Celli
Journal:  Eur Respir J       Date:  2004-01       Impact factor: 16.671

9.  Chemotherapy for patients with non-small cell lung cancer: the surgical setting of the Big Lung Trial.

Authors:  D Waller; M D Peake; R J Stephens; N H Gower; R Milroy; M K B Parmar; R M Rudd; S G Spiro
Journal:  Eur J Cardiothorac Surg       Date:  2004-07       Impact factor: 4.191

10.  Impact of respiratory symptoms and pulmonary function on quality of life of long-term survivors of non-small cell lung cancer.

Authors:  Linda Sarna; Lorraine Evangelista; Donald Tashkin; Geraldine Padilla; Carmack Holmes; Mary Lynn Brecht; Fred Grannis
Journal:  Chest       Date:  2004-02       Impact factor: 9.410

View more
  4 in total

1.  Exercise training undertaken by people within 12 months of lung resection for non-small cell lung cancer.

Authors:  Vinicius Cavalheri; Chris Burtin; Vittoria R Formico; Mika L Nonoyama; Sue Jenkins; Martijn A Spruit; Kylie Hill
Journal:  Cochrane Database Syst Rev       Date:  2019-06-17

Review 2.  Gasotransmitters in the tumor microenvironment: Impacts on cancer chemotherapy (Review).

Authors:  Abbas Salihi; Mohammed A Al-Naqshabandi; Zhikal Omar Khudhur; Zjwan Housein; Harmand A Hama; Ramyar M Abdullah; Bashdar Mahmud Hussen; Twana Alkasalias
Journal:  Mol Med Rep       Date:  2022-05-26       Impact factor: 3.423

3.  A multifactoral analysis of 1452 patients for smoking sensation. An outpatient lab experience.

Authors:  Theodora Tsiouda; Paul Zarogoulidis; Dimitris Petridis; Nikolaos Pezirkianidis; Ioannis Kioumis; Lonny Yarmus; Haidong Huang; Qiang Li; Wolfgang Hohenforst-Schmidt; Konstantinos Porpodis; Dionysios Spyratos; Kosmas Tsakiridis; Georgia Pitsiou; Theodoros Kontakiotis; Paraskevi Argyropoulou; George Kyriazis; Konstantinos Zarogoulidis
Journal:  J Cancer       Date:  2014-05-10       Impact factor: 4.207

4.  Exercise training for people following curative intent treatment for non-small cell lung cancer: a randomized controlled trial.

Authors:  Vinicius Cavalheri; Sue Jenkins; Nola Cecins; Kevin Gain; Martin J Phillips; Lucas H Sanders; Kylie Hill
Journal:  Braz J Phys Ther       Date:  2017-01-13       Impact factor: 3.377

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.